92 related articles for article (PubMed ID: 2477648)
21. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
[TBL] [Abstract][Full Text] [Related]
22. Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.
Nepom BS; Nepom GT; Mickelson E; Antonelli P; Hansen JA
Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6962-6. PubMed ID: 6417660
[TBL] [Abstract][Full Text] [Related]
23. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
24. CD10 and CD44 genes of leukemic cells and malignant cell lines show no evidence of transformation-related alterations.
Kee BL; Dadi HK; Tran-Paterson R; Quackenbush EJ; Andrulis IL; Letarte M
J Cell Physiol; 1991 Sep; 148(3):414-20. PubMed ID: 1833412
[TBL] [Abstract][Full Text] [Related]
25. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
26. The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules.
Schick MR; Levy S
J Immunol; 1993 Oct; 151(8):4090-7. PubMed ID: 8409388
[TBL] [Abstract][Full Text] [Related]
27. Induction of autologous CD4- and CD8-mediated T-cell responses against acute lymphocytic leukemia cell line using apoptotic tumor cell-loaded dendritic cells.
Hatakeyama N; Tamura Y; Sahara H; Suzuki N; Suzuki K; Hori T; Mizue N; Torigoe T; Tsutsumi H; Sato N
Exp Hematol; 2006 Feb; 34(2):197-207. PubMed ID: 16459188
[TBL] [Abstract][Full Text] [Related]
28. HLA-DQ molecular heterogeneity in HLA-DR4-Dw4 consanguineous cell lines.
Fernandez N; Labeta M; Kurpisz M; Solana R; Festenstein H
Dis Markers; 1986 Jun; 4(1-2):191-8. PubMed ID: 3502560
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-induced lymphoblastoid cell lines from seropositive adult donors and their HLA-antigens.
Akiyama N; Ohsawa N; Kusaba R; Inou T; Takada M
Jpn J Exp Med; 1981 Feb; 51(1):1-7. PubMed ID: 6273617
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a lymphoblastoid cell line, SD-1, expressing the p190 bcr-abl chimaeric protein.
Dhut S; Gibbons B; Chaplin T; Young BD
Leukemia; 1991 Jan; 5(1):49-55. PubMed ID: 1847983
[TBL] [Abstract][Full Text] [Related]
31. Human bone marrow cells positive for terminal deoxynucleotidyl transferase (TdT), HLA-DR, and a T cell marker may represent prothymocytes.
van Dongen JJ; Hooijkaas H; Comans-Bitter M; Hählen K; de Klein A; van Zanen GE; van't Veer MB; Abels J; Benner R
J Immunol; 1985 Nov; 135(5):3144-50. PubMed ID: 2413114
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus (EBV) latent membrane protein 1 increases HLA class II expression in an EBV-negative B cell line.
Zhang Q; Brooks L; Busson P; Wang F; Charron D; Kieff E; Rickinson AB; Tursz T
Eur J Immunol; 1994 Jun; 24(6):1467-70. PubMed ID: 8206105
[TBL] [Abstract][Full Text] [Related]
33. Two t(9;22) leukemia cell lines (NALM-24 and NALM-25) with bi-phenotypic characteristics and an EBV-positive B-cell non-leukemia cell line (B262) established from a patient with acute lymphoblastic leukemia.
Matsuo Y; Ariyasu T; Adachi T; Tsubota T; Minowada J
Hum Cell; 1991 Dec; 4(4):339-42. PubMed ID: 1667895
[TBL] [Abstract][Full Text] [Related]
34. Analysis of expression and function of CD40 on normal and leukemic human B cell precursors.
Law CL; Wörmann B; LeBien TW
Leukemia; 1990 Nov; 4(11):732-8. PubMed ID: 1700237
[TBL] [Abstract][Full Text] [Related]
35. Human skin cells synthesize HLA-DR molecules of the same charge and molecular weight as those synthesized by autologous lymphocytes.
Morhenn VB; Charron DJ; Engleman EG
J Invest Dermatol; 1982 Feb; 78(2):125-7. PubMed ID: 6976998
[TBL] [Abstract][Full Text] [Related]
36. A case of HLA-DR negative B-precursor acute lymphoblastic leukemia.
Giotopoulou S; Dokou E; Tzoufi M; Kolaitis N; Vartholomatos G
J Exp Clin Cancer Res; 2003 Dec; 22(4):637-40. PubMed ID: 15053308
[TBL] [Abstract][Full Text] [Related]
37. The role of T cell costimulation by CD80 in the initiation and maintenance of the immune response to human leukemia.
Matsumoto K; Anasetti C
Leuk Lymphoma; 1999 Nov; 35(5-6):427-35. PubMed ID: 10609780
[TBL] [Abstract][Full Text] [Related]
38. Characterization and quantification of solubilised HLA-DR antigens from circulating human monocytes using an immunoblotting procedure.
Hassan J; Feighery C; Bresnihan B; Whelan A
Tissue Antigens; 1987 Oct; 30(4):167-75. PubMed ID: 3317990
[TBL] [Abstract][Full Text] [Related]
39. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
[TBL] [Abstract][Full Text] [Related]
40. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
Fischer H; Dohlsten M; Lindvall M; Sjögren HO; Carlsson R
J Immunol; 1989 May; 142(9):3151-7. PubMed ID: 2785135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
